Metabolic syndrome as a prognostic factor for breast cancer recurrences

International Journal of Cancer

Volumn 119, Issue 1, 2006, Pages 236-238

  Pasanisi, Patrizia ^a   Berrino, Franco ^a   De Petris, Michela ^a   Venturelli, Elisabetta ^a   Mastroianni, Antonio ^a   Panico, Salvatore ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Breast cancer; Metabolic syndrome; Recurrences

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE RECEPTOR; TAMOXIFEN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; ITALY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; TESTOSTERONE BLOOD LEVEL;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; ITALY; METABOLIC SYNDROME X; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TESTOSTERONE;

EID: 33646528017     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21812     Document Type: Article

References (20)

1. Vainio H, Kaaks R, Bianchini F. Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev 2002;11:94-100.
2. Stoll BA. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 1999;53:83-7.
3. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 2004;96:1152-60.
4. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002;11:1361-8.
5. Potischman N, McCulloch CE, Byers T, Houghton L, Nemoto T, Graham S, Campbell TC. Associations between breast cancer, plasma triglycerides, and cholesterol. Nutr Cancer 1991;15:205-15.
6. Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 2002;44:127-38.
7. Muti P, Stanulla M, Micheli A, Krogh V, Freudenheim JL, Yang J, Schunemann HJ, Trevisan M, Berrino F. Markers of insulin resistance and sex steroid hormone activity in relation to breast cancer risk: a prospective analysis of abdominal adiposity, sebum production, and hirsutism (Italy). Cancer Causes Control 2000;11:721-30.
8. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C. Hypertension and hormone-related neoplasms in women. Hypertension 1999;34:320-5.
9. Malin A, Dai Q, Yu H, Shu XO, Jin F, Gao YT, Zheng W. Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma. Cancer 2004;100:694-700.
10. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-6.
11. Kaaks R. Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 1996;7:605-25.
12. Berrino F, Pasanisi P, Bellati C, Venturelli E, Krogh V, Mastroianni A, Berselli E, Muti P, Secreto G. Serum testosterone levels and breast cancer recurrence. Int J Cancer 2005;113:499-502.
13. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002;20:42-51.
14. Kumar NB, Cantor A, Allen K, Cox CE. Android obesity at diagnosis and breast carcinoma survival: evaluation of the effects of anthropometric variables at diagnosis, including body composition and body fat distribution and weight gain during life span, and survival from breast carcinoma. Cancer 2000;88:2751-7.
15. Tornberg S, Carstensen J. Serum β-lipoprotein, serum cholesterol and Quetelet's index as predictors for survival of breast cancer patients. Eur J Cancer 1993;29A:2025-30.
16. Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA 2001;285:2486-97.
17. Berrino F, Bellati C, Oldani S, Mastroianni A, Allegro G, Berselli E, Venturelli E, Cavalleri A, Cambie M, Pala V, Pasanisi P, Secreto G. DIANA trials on diet and endogenous hormones. IARC Sci Publ 2002;156:439-44.
18. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
19. Kaaks R, Bellati C, Venturelli E, Rinaldi S, Secreto G, Biessy C, Pala V, Sieri S, Berrino F. Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the diet and androgens (DIANA) randomised trial. Eur J Clin Nutr 2003;57:1079-88.
20. Berrino F, Bellati C, Secreto G, Camerini E, Pala V, Panico S, Allegro G, Kaaks R. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev 2001;10:25-33.